<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: This study aimed to identify a novel biomarker or a target of treatment for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>EXPERIMENTAL DESIGN: The expression profiles of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells in 104 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> were examined using laser microdissection and oligonucleotide microarray analysis </plain></SENT>
<SENT sid="2" pm="."><plain>Overexpression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells, especially in patients with distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e>, was a prerequisite to select candidate genes </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of candidate genes was investigated by quantitative reverse transcriptase PCR (RT-PCR) in 77 patients as a validation study </plain></SENT>
<SENT sid="4" pm="."><plain>We analyzed the protein expression and localization of the candidate gene by immunohistochemical study and investigated the relationship between protein expression and clinicopathologic features in 274 CRC patients </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Using microarray analysis, we identified 6 candidate genes related to distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="6" pm="."><plain>Among these genes, osteoprotegerin (OPG) is known to be associated with <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> in several <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> through inhibition of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> via neutralization of the function of TNF-related <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-inducing ligand </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of OPG in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues was significantly higher in patients with distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> than those without <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Overexpression of OPG protein was associated with significantly worse overall survival and relapse-free survival </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, overexpression of the OPG protein was an independent risk factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> recurrence </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Overexpression of OPG may be a predictive biomarker of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> recurrence and a target for treatment of this disease </plain></SENT>
</text></document>